O'Malley Brendan M. 4

What Happened
Brendan M. O'Malley, Abeona Therapeutics' Senior Vice President and Chief Legal Officer, disposed of 13,578 shares on 2026-01-22 in open-market sales. The reported weighted-average price was $5.33, with proceeds of approximately $72,383. This sale was reported as a routine disposition (sale), not a purchase.

Key Details

• Transaction date: 2026-01-22 (filed on the same date).
• Transaction type/code: Sale (S).
• Shares sold: 13,578.
• Price: weighted average $5.33; individual sale prices ranged $5.33–$5.38 (footnote F2).
• Proceeds: ~$72,383.
• Reason noted: Sale to cover tax obligations from vesting of restricted stock awards (footnote F1).
• Shares owned after transaction: Not specified in the supplied filing.
• Filing timeliness: Reported the same day as the transaction (timely).

Context
Sales to cover tax withholding on vested awards are common and typically routine; they do not necessarily signal a view on the company’s prospects. The weighted-average price reflects multiple transactions; the filer offers to provide a price-by-price breakdown upon request.